Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Lentiviruses belong to the family Retroviridae and are enveloped viruses with a single-stranded RNA genome. They are widely used in a variety of biological and medical research fields due to their ability to infect both dividing and non-dividing cells. This versatility makes lentiviral vectors invaluable in gene therapy, creating transgenic models, and conducting functional genomic studies.
Lentivirus packaging is a key method in molecular biology for delivering genetic material to target cells. By utilizing recombinant lentiviral particles, this protocol allows for efficient gene transfer, which is critical for research and therapeutic applications. This review discusses detailed lentiviral packaging protocols and highlights best practices for achieving optimal viral titers.
1. Biological Safety Cabinet (BSC)
2. Centrifuge
3. Microscope
4. Pipettes and Pipette Tips
5. 10 cm Culture Dishes
6. Serum-Free and Antibiotic-Free Medium
7. Sterile Filtration Units
1. DNA Plasmids
2. Transfection Reagent
3. Cell Culture Media
4. Fetal Bovine Serum (FBS)
5. Phosphate-Buffered Saline (PBS)
6. Lentivirus Titer Kit (optional)
7. VSVG Glycoprotein Expressing Plasmid
1. Plasmid preparation:
(1) Sufficient expression DNA is critical. Typically, 10 µg of plasmid is required per 10 cm dish.
(2) Standard bacterial transformation protocols are recommended for plasmid amplification. E. coli DH5-alpha strains are preferred for high yields and minimal risk of recombination.
2. Cell culture preparation (Day 1):
(1) The day before transfection, seed cells at 40-50% confluence.
(2) On the day of transfection, aim for 70-80% confluence to ensure optimal viral yield.
3. Transfection (Day 2):
(1) Prepare transfection complexes with specific ratios of expression vector, packaging mix, and transfection reagent.
(2) Incubate the DNA-transfection reagent mixture before adding to cells. Initial incubation time is 5-8 hours, ensuring gentle addition to avoid cell detachment.
(3) Supplement with fetal bovine serum and incubate overnight.
4. Harvest and processing (Days 3-5):
(1) Collect and process supernatant to concentrate viral particles. The use of centrifugation and filtration techniques facilitates the removal of cellular debris.
(2) Subsequent storage of viral particles at -80°C maintains integrity and potency.
5. Results:
(1) Successful protocols yielded viral titers in the 10^6 IU/mL range.
(2) Monitoring cell fusion resulting from VSVG glycoprotein expression is critical to identifying syncytium formation - a normal and harmless phenomenon.
1. Ensure that the cell confluency on the day of transfection is between 70-80%. This balance is critical, as over-confluent cells may result in reduced transfection efficiency, while under-confluent cells may not produce enough viral particles.
2. Use endotoxin-free and highly pure plasmid preparations. Contaminants can severely impact transfection efficiency and cell health. It is also beneficial to ensure accurate plasmid concentration using a DNA quantification method to maintain consistency.
3. Fine-tune the amount of transfection reagent used. More is not always better, as excess reagent can lead to cytotoxicity. Performing a reagent gradient can help determine the optimal amount to maximize viral yield without harming the cells.
1. Low virus titer:
(1) Check cell health: Ensure that producer cells are healthy and not stressed prior to transfection. High cell mortality or contamination can result in low virus yields.
(2) Verify plasmid integrity: Confirm that all plasmids (expression, packaging, and envelope) are intact and of high quality. Sequencing or restriction enzyme digestion can verify integrity.
(3) Optimize transfection reagent: Re-evaluate the ratio and total amount of plasmid DNA to transfection reagent. Small changes can significantly affect efficiency.
2. High cytotoxicity:
(1) Reduce transfection reagent volume: Excess transfection reagent can be toxic to cells. Titration experiments can help determine the optimal amount.
(2) Evaluate media conditions: Ensure that the serum-free media used for transfection does not adversely affect cell health. Switching to a different batch may help.
3. Low transfection efficiency:
(1) Enhance mixing of DNA and reagents: Ensure that DNA and transfection reagent are gently and thoroughly mixed to form homogenous transfection complexes.
(2) Ensure optimal incubation time: Ensure that the incubation time for transfection complex formation is adhered to before adding transfection complexes to cells.
Copyright © Creative Biogene. All rights reserved.